Hum. Reprod. Advance Access originally published online on July 22, 2004
Human Reproduction 2004 19(9):2043-2051; doi:10.1093/humrep/deh418
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The FLUSH TrialFlushing with Lipiodol for Unexplained (and endometriosis-related) Subfertility by Hysterosalpingography: a randomized trial
1 University of Auckland Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, 2 Fertility Plus, National Women's Hospital, Auckland, 3 University Specialists, Mercy Specialist Centre, Epsom, Auckland and 4 Auckland Radiology Group, 641 Manukau Road, Royal Oak, Auckland, New Zealand
5 To whom correspondence should be addressed at: University of Auckland Department of Obstetrics and Gynaecology, National Women's Hospital, Auckland, New Zealand. Email: n.johnson{at}auckland.ac.nz
BACKGROUND: To assess the effectiveness of flushing with the oil-soluble contrast medium lipiodol in women with unexplained infertility. METHODS: An open randomized controlled trial design in a single centre secondary and tertiary level infertility service setting. A total of 158 women with unexplained infertility were stratified into two populations: 96 women without confirmed endometriosis and 62 women with endometriosis who had normal Fallopian tubes and ovaries. Randomization was computer-generated, with allocation concealment by opaque sequentially numbered envelopes. Lipiodol flushing was tested versus no intervention. The main outcome measures were clinical pregnancy (assessed at 6 months following randomization) and live birth. RESULTS: Lipiodol flushing resulted in a significant increase in pregnancy [48.0 versus 10.8%, relative risk (RR) 4.44, 95% confidence interval (CI) 1.6112.21] and live birth (40.0 versus 10.8%, RR 3.70, 95% CI 1.3010.50) rates versus no intervention for women with endometriosis, although there was no significant difference in pregnancy (33.3 versus 20.8%, RR 1.60, 95% CI 0.813.16) or live birth (27.1 versus 14.6%, RR 1.86, 95% CI 0.814.25) rates for women with unexplained infertility without confirmed endometriosis. CONCLUSIONS: Lipiodol flushing is an effective treatment for couples with unexplained infertility (based on meta-analysis data), but is particularly effective for women with endometriosis who have normal Fallopian tubes and ovaries.
Key words: endometriosis/lipiodol/oil soluble contrast media/randomized trial/unexplained infertility
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Schulke, M. Berbic, F. Manconi, N. Tokushige, R. Markham, and I. S. Fraser Dendritic cell populations in the eutopic and ectopic endometrium of women with endometriosis Hum. Reprod., July 1, 2009; 24(7): 1695 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lindborg, J. Thorburn, C. Bergh, and A. Strandell Influence of HyCoSy on spontaneous pregnancy: a randomized controlled trial Hum. Reprod., May 1, 2009; 24(5): 1075 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.P. Johnson, R. Kwok, A.W. Stewart, M. Saththianathan, W.E. Hadden, and L.W. Chamley Lipiodol fertility enhancement: two-year follow-up of a randomized trial suggests a transient benefit in endometriosis, but a sustained benefit in unexplained infertility Hum. Reprod., November 1, 2007; 22(11): 2857 - 2862. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Johnson, W. E. Hadden, L. W. Chamley, D. B. Spring, H. E. Barkan, A. J. Yun, and P. Y. Lee Fertility Enhancement by Hysterosalpingography with Oil-Soluble Contrast Media: Reality Not Myth Am. J. Roentgenol., December 1, 2005; 185(6): 1654 - 1657. [Full Text] [PDF] |
||||
![]() |
P.K. Jothilakshmi and A.J.S. Watson 'Flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography' Hum. Reprod., March 1, 2005; 20(3): 843 - 843. [Full Text] [PDF] |
||||

